Acerus Pharmaceuticals (TSX:ASP) Other Long Term Assets : C$0.00 Mil (As of Sep. 2022)

View and export this data going back to 2009. Start your Free Trial

What is Acerus Pharmaceuticals Other Long Term Assets?

Acerus Pharmaceuticals's other long-term assets for the quarter that ended in Sep. 2022 was C$0.00 Mil.

Acerus Pharmaceuticals's quarterly other long-term assets increased from Mar. 2022 (C$-0.00 Mil) to Jun. 2022 (C$0.00 Mil) and increased from Jun. 2022 (C$0.00 Mil) to Sep. 2022 (C$0.00 Mil).

Acerus Pharmaceuticals's annual other long-term assets increased from Dec. 2019 (C$-0.00 Mil) to Dec. 2020 (C$-0.00 Mil) and increased from Dec. 2020 (C$-0.00 Mil) to Dec. 2021 (C$0.00 Mil).

Acerus Pharmaceuticals Other Long Term Assets Historical Data

The historical data trend for Acerus Pharmaceuticals's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acerus Pharmaceuticals Other Long Term Assets Chart

Acerus Pharmaceuticals Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Other Long Term Assets

Get a 7-Day Free Trial

Acerus Pharmaceuticals Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Other Long Term Assets	Get a 7-Day Free Trial															-	-	-	-	-

Acerus Pharmaceuticals Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Acerus Pharmaceuticals (TSX:ASP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Acerus Pharmaceuticals Corp (TSX:ASP) » Definitions » Other Long Term Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

7025 Langer Drive, Suite 205, Mississauga, ON, CAN, L5N 0E8

Website

https://www.aceruspharma.com

Acerus Pharmaceuticals Corp is a specialty pharmaceutical company focused on the development, manufacture, marketing and distribution of branded products that improve patient experience, with a primary focus on the field of men's health. Its foundational product includes NATESTO, a testosterone therapy based on nasal gel technology. The company commercializes its products via its salesforce in the United States and Canada, and through a global network of licensed distributors in other territories.

Executives

Norma Beauchamp	Director
Stephen Robert Gregory	Director
Edward Joseph Gudaitis	Director, Senior Officer